Safety and feasibility of orbital atherectomy for the treatment of calcified coronary lesions
Catheterization and Cardiovascular Interventions2013Vol. 81(7), pp. 1134–1139
Citations Over TimeTop 10% of 2013 papers
Abstract
The ORBIT I trial suggests that the OAS may offer an effective method to change compliance of calcified coronary lesions to facilitate optimal stent placement in these difficult to treat patients. A larger trial is required to establish safety and overall effectiveness of the OAS in treating calcified coronary lesions.
Related Papers
- → Impact of coronary lesion complexity in percutaneous coronary intervention: one-year outcomes from the large, multicentre e-Ultimaster registry(2020)70 cited
- → Analysis of Target Lesion Length Before Coronary Artery Stenting Using Angiography and Near-Infrared Spectroscopy Versus Angiography Alone(2011)46 cited
- → Relationship Between Primary Patency and Lesion Length Following Bare Nitinol Stent Placement for Femoropopliteal Disease(2015)24 cited
- → Optical coherence tomography predictors of target vessel myocardial infarction after provisional stenting in patients with coronary bifurcation disease(2020)5 cited
- → Side branch long lesion with main vessel vulnerable plaques by optical coherence tomography predict target-vessel myocardial infarction after provisional stenting in patients with coronary bifurcation(2020)